A detailed history of Gts Securities LLC transactions in Novartis Ag stock. As of the latest transaction made, Gts Securities LLC holds 12,512 shares of NVS stock, worth $1.65 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
12,512
Previous 5,122 144.28%
Holding current value
$1.65 Million
Previous $620 Million 158.87%
% of portfolio
0.06%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$113.5 - $129.73 $838,765 - $958,704
7,390 Added 144.28%
12,512 $1.6 Billion
Q2 2025

Aug 08, 2025

BUY
$101.96 - $121.01 $93,089 - $110,482
913 Added 21.69%
5,122 $620 Million
Q1 2025

May 15, 2025

SELL
$97.14 - $115.57 $528,538 - $628,816
-5,441 Reduced 56.38%
4,209 $469 Million
Q4 2024

Feb 18, 2025

BUY
$96.78 - $117.18 $141,298 - $171,082
1,460 Added 17.83%
9,650 $939 Million
Q3 2024

Nov 13, 2024

BUY
$106.13 - $120.89 $869,204 - $990,089
8,190 New
8,190 $942,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $283B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.